Two Trials at The Istituto Nazionale Dei Tumori (INT) in Milan

Submitted by johnny_b on Mon, 08/01/2011 - 09:39
Forums: 
Clinical Trials
  1. Phase II study of lapatinib in EGFR/HER2 positive advanced chordoma
  2. Phase II study of imatinib in combination with RAD001 (everolimus) in patients with advanced chordoma

See: The Announcement on the Chordoma Foundation's Webpage for more information.

© 2011 John Bjorn Nelson. Drupal theme by Kiwi Themes.